Skip to main content
. 2017 Jan 5;32(2):283–297. doi: 10.1093/mutage/gew059

Figure 2.

Figure 2.

FCM analysis of human lymphoblastoid cells (TK6) following aerolysin and PI treatment. Flow cytometric outputs following consecutive aerolysin and PI treatment on parental TK6 strain (A) and FACS enriched CD59 positive (B) and negative populations (C).